Results revealed increased expression of miRNA associated with increase p38 activity, including miR-34 (a p53 target), miR-17, miR-9, miR-199 (a tumor suppressor that targets c-Met), miR-125 (previously found to be a tumor suppressor in breast cancer), which associate with increased p38 MAPK activity (68–72). The gene discussed is TP53; the disease is breast carcinoma.